Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
Syros Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: April 21, 2023
Syros Pharmaceuticals reported fiscal year 2022 executive compensation information on April 21, 2023.
In 2022, three executives at Syros Pharmaceuticals received on average a compensation package of $2.3M, a 7% increase compared to previous year.
Average pay of disclosed executives at Syros Pharmaceuticals
Nancy Simonian, Chief Executive Officer, received $3.5M in total, which increased by 12% compared to 2021. 45% of Simonian's compensation, or $1.6M, was in stock awards. Simonian also received $317K in non-equity incentive plan, $975K in option awards, $637K in salary, as well as $2K in other compensation.
David A. Roth, Chief Medical Officer, received a compensation package of $1.8M, which increased by 9% compared to previous year. 40% of the compensation package, or $699K, was in stock awards.
Eric R. Olson, Chief Scientific Officer, earned $1.7M in 2022, a 18% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 21, 2023.